Related references
Note: Only part of the references are listed.Mucosal Vaccination with a Multivalent, Live-Attenuated Vaccine Induces Multifactorial Immunity against Pseudomonas aeruginosa Acute Lung Infection
Akinobu Kamei et al.
INFECTION AND IMMUNITY (2011)
Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection
T. Secher et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF
Anja Krause et al.
VACCINE (2011)
Delivery of antigens by viral vectors for vaccination
Anja Krause et al.
THERAPEUTIC DELIVERY (2011)
Adenovirus 5 serotype vector-specific immunity and HIV-1 infection: a tale of T cells and antibodies
M. Patricia D'Souza et al.
AIDS (2010)
Preclinical In Vitro and In Vivo Characterization of the Fully Human Monoclonal IgM Antibody KBPA101 Specific for Pseudomonas aeruginosa Serotype IATS-O11
Michael P. Horn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Protection against Pseudomonas aeruginosa lung infection in mice by recombinant OprF-pulsed dendritic cell immunization
Lucia Peluso et al.
BMC MICROBIOLOGY (2010)
Synthetic Peptide Vaccine Development: Designing Dual Epitopes into a Single Pilin Peptide Immunogen Generates Antibody Cross-reactivity between Two Strains of Pseudomonas aeruginosa
Clifton Hackbarth et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2010)
In vitro and in vivo T cell responses in mice during bronchopulmonary infection with mucoid Pseudomonas aeruginosa
M. M. STEVENSON et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
The immune system vs. Pseudomonas aeruginosa biofilms
Peter Ostrup Jensen et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2010)
Evaluation of Flagella and Flagellin of Pseudomonas aeruginosa as Vaccines
Victoria L. Campodonico et al.
INFECTION AND IMMUNITY (2010)
Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung
Michael Hogardt et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2010)
Formulation and Immunogenicity of a Potential Multivalent Type III Secretion System-Based Protein Vaccine
Aaron P. Markham et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
A New Adenovirus Based Vaccine Vector Expressing an Eimeria tenella Derived TLR Agonist Improves Cellular Immune Responses to an Antigenic Target
Daniel M. Appledorn et al.
PLOS ONE (2010)
Systemic, nasal and oral live vaccines against Pseudomonas aeruginosa: A clinical trial of immunogenicity in lower airways of human volunteers
Dirk Bumann et al.
VACCINE (2010)
OprF/I-vaccinated sera inhibit binding of human interferon-gamma to Pseudomonas aeruginosa
Bin Ding et al.
VACCINE (2010)
Novel adenovirus vector-based vaccines for HIV-1
Dan H. Barouch
CURRENT OPINION IN HIV AND AIDS (2010)
Pharmacokinetics and Safety Profile of the Human Anti-Pseudomonas aeruginosa Serotype O11 Immunoglobulin M Monoclonal Antibody KBPA-101 in Healthy Volunteers
Hedvika Lazar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Active immunization using exotoxin A confers protection against Pseudomonas aeruginosa infection in a mouse burn model
Ali Manafi et al.
BMC MICROBIOLOGY (2009)
Therapy with anti-flagellin A monoclonal antibody limits Pseudomonas aeruginosa invasiveness in a mouse burn wound sepsis model
Yoav Barnea et al.
BURNS (2009)
Advantages of a Synthetic Peptide Immunogen Over a Protein Immunogen in the Development of an Anti-Pilus Vaccine for Pseudomonas aeruginosa
Daniel J. Kao et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
An Engineered Human Antibody Fab Fragment Specific for Pseudomonas aeruginosa PcrV Antigen Has Potent Antibacterial Activity
Mark Baer et al.
INFECTION AND IMMUNITY (2009)
A Fusion Protein Vaccine Containing OprF Epitope 8, OprI, and Type A and B Flagellins Promotes Enhanced Clearance of Nonmucoid Pseudomonas aeruginosa
Eric T. Weimer et al.
INFECTION AND IMMUNITY (2009)
Replication-Defective Adenovirus Vectors with Multiple Deletions Do Not Induce Measurable Vector-Specific T Cells in Human Trials
Richard A. Koup et al.
JOURNAL OF VIROLOGY (2009)
Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans
Kara L. O'Brien et al.
NATURE MEDICINE (2009)
Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T cells
Natalie A. Hutnick et al.
NATURE MEDICINE (2009)
Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice
Kiyoshi Moriyama et al.
MICROBIOLOGY AND IMMUNOLOGY (2009)
Immune responses in the airways by nasal vaccination with systemic boosting against Pseudomonas aeruginosa in chronic lung diseased
Stephan Sorichter et al.
VACCINE (2009)
Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa
Eric T. Weimer et al.
VACCINE (2009)
Immunization with a Pseudomonas aeruginosa 1244 pilin provides O-antigen-specific protection
Joseph Horzempa et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells
Matthieu Perreau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
The failed HIV Merck vaccine study: A step back or a launching point for future vaccine development?
Rafick-Pierre Sekaly
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa
Gregory P. Priebe et al.
JOURNAL OF IMMUNOLOGY (2008)
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis
M. Juliana McElrath et al.
LANCET (2008)
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
Susan P. Buchbinder et al.
LANCET (2008)
Rapid/sustained anti-anthrax passive immunity mediated by co-administration of Ad/AAV
Bishnu P. De et al.
MOLECULAR THERAPY (2008)
rBCG Induces Strong Antigen-Specific T Cell Responses in Rhesus Macaques in a Prime-Boost Setting with an Adenovirus 35 Tuberculosis Vaccine Vector
Isabelle Magalhaes et al.
PLOS ONE (2008)
Attachment of the outer membrane lipoprotein (Opr1) of Pseudomonas aeruginosa to the mucosal surfaces of the respiratory and digestive tract of chickens
Karolien Loots et al.
VACCINE (2008)
Vaccines and immunotherapy against Pseudomonas aeruginosa
Gerd Doering et al.
VACCINE (2008)
Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV
Davor Skaricic et al.
VIROLOGY (2008)
Protective immunity to Pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF
Stefan Worgall et al.
JOURNAL OF VIROLOGY (2007)
Animal protection and structural studies of a consensus sequence vaccine targeting the receptor binding domain of the type IV pilus of Pseudomonas aeruginosa
Daniel J. Kao et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa:: A clinical phase I/II study
Ulrich Baumann et al.
RESPIRATORY RESEARCH (2007)
Blocking of the TLR5 activation domain hampers protective potential of flagellin DNA vaccine
Sukumar Saha et al.
JOURNAL OF IMMUNOLOGY (2007)
A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients
Gerd Doering et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections
Antonio DiGiandomenico et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Synthesis and characterization of Pseudomonas aeruginosa alginate-tetanus toxoid conjugate
Nasim Kashef et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Multivalent DNA vaccine protects mice against pulmonary infection caused by Pseudomonas aeruginosa
Sukumar Saha et al.
VACCINE (2006)
The AlgT-dependent transcriptional regulator AmrZ (AlgZ) inhibits flagellum biosynthesis in mucoid, nonmotile Pseudomonas aeruginosa cystic fibrosis isolates
Anne H. Tart et al.
JOURNAL OF BACTERIOLOGY (2006)
Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunity
Anja Krause et al.
JOURNAL OF VIROLOGY (2006)
Mechanisms of antimicrobial resistance in bacteria
Fred C. Tenover
AMERICAN JOURNAL OF INFECTION CONTROL (2006)
Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice
Minoru Ohama et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2006)
Development of nonhuman adenoviruses as vaccine vectors
DS Bangari et al.
VACCINE (2006)
Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice
MA Hoelscher et al.
LANCET (2006)
Structures of the core oligosaccharide and O-units in the R- and SR-type lipopolysaccharides of reference strains of Pseudomonas aeruginosa O-serogroups
OV Bystrova et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2006)
Recognition of host immune activation by Pseudomonas aeruginosa
LC Wu et al.
SCIENCE (2005)
Pseudomonas aeruginosa:: the potential to immunise against infection
E Sedlak-Weinstein et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes
ZZ Lai et al.
VACCINE (2005)
Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid
S Worgall et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge
AN Neely et al.
BURNS (2005)
Adenovirus-based genetic vaccines for biodefense
JL Boyer et al.
HUMAN GENE THERAPY (2005)
Adenovirus vector-based vaccines for human immunodeficiency virus type 1
DH Barouch et al.
HUMAN GENE THERAPY (2005)
Significant differences in type IV pilin allele distribution among Pseudomonas aeruginosa isolates from cystic fibrosis (CF) versus non-CIF patients
JV Kus et al.
MICROBIOLOGY-SGM (2004)
Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections
U Baumann et al.
VACCINE (2004)
Crystallographic analysis of the Pseudomonas aeruginosa strain K122-4 monomeric pilin reveals a conserved receptor-binding architecture
GF Audette et al.
BIOCHEMISTRY (2004)
Passive antibody therapy for infectious diseases
A Casadevall et al.
NATURE REVIEWS MICROBIOLOGY (2004)
Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers
WG Metzger et al.
VACCINE (2004)
Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains
GB Pier et al.
JOURNAL OF IMMUNOLOGY (2004)
Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection
AB Lang et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Pseudomonas aeruginosa flagellin and alginate elicit very distinct gene expression patterns in airway epithelial cells:: Implications for cystic fibrosis disease
LM Cobb et al.
JOURNAL OF IMMUNOLOGY (2004)
Pseudomonas aeruginosa-specific IgG1 and IgG2 subclasses in enhancement of pulmonary clearance following passive immunisation in the rat
ML Dunkley et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2003)
Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF-OprI vaccine in burn patients
E Mansouri et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2003)
Progress toward the development of a bacterial vaccine vector that induces high-titer long-lived broadly neutralizing antibodies against HIV-1
TR Fouts et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2003)
Mucosal vaccination with a recombinant OprF-I vaccine of Pseudomonas aeruginosa in healthy volunteers:: comparison of a systemic vs. a mucosal booster schedule
K Göcke et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2003)
Synthetic peptide vaccine and antibody therapeutic development: Prevention and treatment of Pseudomonas aeruginosa
PJ Cachia et al.
BIOPOLYMERS (2003)
Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules - potential benefits in vaccine design
OB Herrera et al.
VACCINE (2002)
Glycosylation of Pseudomonas aeruginosa 1244 pilin:: glycan substrate specificity
A DiGiandomenico et al.
MOLECULAR MICROBIOLOGY (2002)
Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV
DW Frank et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Therapeutic administration of anti-PcrV F(ab′)2 in sepsis associated with Pseudomonas aeruginosa
N Shime et al.
JOURNAL OF IMMUNOLOGY (2001)
Cutting edge: Bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression
AT Gewirtz et al.
JOURNAL OF IMMUNOLOGY (2001)
Structure of a pilin monomer from Pseudomonas aeruginosa -: Implications for the assembly of pili
DW Keizer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
High level expression of a human rabies virus-neutralizing monoclonal antibody by a rhabdovirus-based vector
K Morimoto et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Safety and immunogenicity of an intranasal Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers
M Larbig et al.
VACCINE (2001)
Expression and testing of Pseudomanas aeruginosa vaccine candidate proteins prepared with the Caulobacter crescentus S-layer protein expression system
E Umelo-Njaka et al.
VACCINE (2001)
Comparison of two immunization schedules for a Pseudomonas aeruginosa outer membrane proteins vaccine in burn patients
DK Kim et al.
VACCINE (2000)
Mice immunized with DNA encoding a modified Pseudomonas aeruginosa exotoxin A develop protective immunity against exotoxin intoxication
JW Shiau et al.
VACCINE (2000)
Development of a preventive vaccine for Ebola virus infection in primates
NJ Sullivan et al.
NATURE (2000)
Crystal structure of Pseudomonas aeruginosa PAK pilin suggests a main-chain-dominated mode of receptor binding
B Hazes et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Immunization with a Pseudomonas aeruginosa elastase peptide reduces severity of experimental lung infections due to P-aeruginosa or Burkholderia cepacia
PA Sokol et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy
NG Lee et al.
VACCINE (2000)
The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type
C Moser et al.
APMIS (2000)
Analysis of immunization with DNA encoding Pseudomonas aeruginosa exotoxin A
KS Denis-Mize et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2000)
Share Paper
